Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Inventory Average (2022 - 2025)

Historic Inventory Average for InMed Pharmaceuticals (INM) over the last 4 years, with Q4 2025 value amounting to $919352.5.

  • InMed Pharmaceuticals' Inventory Average fell 2086.24% to $919352.5 in Q4 2025 from the same period last year, while for Dec 2025 it was $919352.5, marking a year-over-year decrease of 2086.24%. This contributed to the annual value of $1.1 million for FY2025, which is 2290.31% down from last year.
  • InMed Pharmaceuticals' Inventory Average amounted to $919352.5 in Q4 2025, which was down 2086.24% from $925990.0 recorded in Q3 2025.
  • In the past 5 years, InMed Pharmaceuticals' Inventory Average ranged from a high of $2.1 million in Q3 2022 and a low of $887571.5 during Q2 2025
  • In the last 4 years, InMed Pharmaceuticals' Inventory Average had a median value of $1.2 million in 2022 and averaged $1.3 million.
  • As far as peak fluctuations go, InMed Pharmaceuticals' Inventory Average plummeted by 4463.68% in 2023, and later skyrocketed by 2372.25% in 2024.
  • Over the past 4 years, InMed Pharmaceuticals' Inventory Average (Quarter) stood at $1.7 million in 2022, then tumbled by 44.64% to $938968.0 in 2023, then rose by 23.72% to $1.2 million in 2024, then fell by 20.86% to $919352.5 in 2025.
  • Its last three reported values are $919352.5 in Q4 2025, $925990.0 for Q3 2025, and $887571.5 during Q2 2025.